首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1737076

全球總體基因體學套件市場規模（按類型、應用、地區、範圍和預測）

Global Metagenomics Kits Market Size By Type (Library Preparation Kits, Metagenomic Sequencing Kits), By Application (Drug Discovery, Clinical Diagnostics), By Geographic Scope And Forecast

出版日期: 2025年05月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

總體基因體學套件的市場規模與預測

2024 年總體基因體學套件市場規模價值 78 億美元，預計到 2032 年將達到 122 億美元，2026 年至 2032 年的複合年成長率為 7.4%。

總體基因體學在各行各業的使用案例不斷增多，政府和私營部門對大型測序計劃的投資不斷增加，慢性病病例的增加以及測序技術的突破，這些都是推動全球總體基因體學套件市場發展的關鍵因素。本研究報告對全球總體基因體學套件市場進行了全面評估，並深入分析了關鍵細分市場、趨勢、市場促進因素、競爭格局以及影響市場的關鍵因素。

定義全球總體基因體學套件市場

總體基因體學套件旨在利用半導體序列測定技術，快速、全面、廣泛地研究混合微生物群落。總體基因體學套件可透過聚合酵素鏈鎖反應擴增細菌高變異區。宏基因組學總體基因體學套件用於研究元基因組，宏基因組是直接從環境樣本中提取的遺傳物質。作為分析微生物族群與其宿主族群之間關聯的基礎資源，元基因組組樣本是人類微生物組計劃所必需的。

全球總體基因體學套件市場概況

總體基因體學是利用現代基因組學工具直接在自然環境中研究微生物群落的技術，無需分離特定物種或在實驗室中培養，從而刺激了市場需求。總體基因體學具有監測污染物對生態系影響的潛力，並增強了污染環境的治理策略。元基因組分析已用於定義構成人類微生物組的微生物群落，有助於理解可能與人類健康相關的微生物組變化。由於此類應用的興起，總體基因體學套件市場在預測期內預計將持續成長。癌症等慢性疾病的發生率不斷上升，正推動全球基因的研究。

慢性病發病率的上升，以及研發治療藥物的研發活動的不斷增加，推動了對總體基因體學套件的需求。此外，人們對個體化醫療的日益關注也有望推動市場發展。然而，在低度開發國家，大學的研發高度依賴外部資金。儘管世界各國政府和私人實體都在努力資助研究，但許多研究機構和學術機構在購買和使用昂貴的現代化設備和技術方面仍面臨預算限制。因此，預計在預測期內，總體基因體學套件市場的擴張將受到阻礙。

The rising use of metagenomics across varied areas, increased government and private sector investment in large-scale sequencing projects, an increase in chronic illness cases, and breakthroughs in sequencing technology are some of the primary reasons driving the worldwide Metagenomics Kits Market. The Global Metagenomics Kits Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Metagenomics Kits Market Definition

The metagenomics kit is intended for a quick, thorough, and broad-reaching study of a mixed microbial community utilizing a semiconductor sequencing technique. The Metagenomics kit enables polymerase chain reaction amplification of bacteria's hypervariable areas. Metagenomics kits are used to investigate metagenomes, which are genetic materials extracted directly from environmental samples. As a fundamental resource for analyzing the link between microbial populations and the persons they inhabit, the human microbiome project requires a metagenomic sample.

Global Metagenomics Kits Market Overview

Metagenomics is the use of contemporary genomics tools to investigate communities of microbial organisms directly in their natural settings, eliminating the need for isolation and lab cultivation of specific species and therefore increasing market demand. Metagenomics has the potential to enhance tactics for monitoring the impact of contaminants on ecosystems and cleaning up polluted settings. The metagenomic analysis is being used to define the microbial communities that are a component of the human microbiome, which aids in understanding the changes in the human microbiome that can be linked to human health. The market for metagenomics kits may expand throughout the forecast period as a result of such applications. The increasing prevalence of chronic illnesses such as cancer has fueled global genetic research.

The rise in chronic illnesses, along with increased research and development activities to discover therapeutic medicines, has increased the demand for metagenomic kits. Furthermore, increased awareness of customized medicine is expected to push the market. However, in underdeveloped nations, university R&D is heavily reliant on outside financing. Despite ongoing attempts by governments and private organizations to offer funds for research across the world, numerous research and academic institutes confront budget limits when it comes to purchasing and utilizing modern and high-priced equipment and technology. As a result, the expansion of the Metagenomics Kits Market is projected to be hampered during the forecast period.

Global Metagenomics Kits Market: Segmentation Analysis

The Global Metagenomics Kits Market is segmented based on Type, Application, And Geography.

Metagenomics Kits Market, By Type

Library Preparation Kits
Metagenomic Sequencing Kits
Sample Extraction Kits

Based on Type, The market is segmented into Library Preparation Kits, Metagenomic Sequencing Kits, and Sample Extraction Kits. The Metagenomic Sequencing Kits segment category had the highest market share of the Metagenomics Kits Market and is predicted to develop at a substantial rate due to advances in DNA sequencing and an increase in the expansion of metagenomics applications driving the growth of the Global Metagenomics Kits Market.

Metagenomics Kits Market, By Application

Drug Discovery
Clinical Diagnostics
Environmental Applications
Others

Based on Application, The market is segmented into Drug Discovery, Clinical Diagnostics, Environmental Applications, and Others. In 2021, the Drug Discovery category held the greatest proportion of the Metagenomics Kits Market. This segment's substantial share may be ascribed to increased research efforts for innovative medication discovery and rising drug development collaborations between market participants, academic institutions, and pharmaceutical corporations.

Metagenomics Kits Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Geography, The Global Metagenomics Kits Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. In 2021, North America held the greatest proportion of the Metagenomics Kits Market. The rising uses of metagenomics in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions are driving the expansion of the North American Metagenomics Kits Market.

Key Players

The "Global Metagenomics Kits Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Perkin Elmer Inc., Promega Connections, Thermo Fisher Scientific, Illumina, Inc., Merck KGaA, QIAGEN N.V., Novogene Co., Ltd., Bio-Rad Laboratories Inc., BGI Group, DNAstar, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In January 2021, Illumina (US) introduced Illumina Connected Analytics (ICA), a new and integrated bioinformatics tool for managing, analyzing, and exploring massive amounts of multi-omics data.
In December 2020, Using the metagenomics technique, Beijing Tongren Hospital initiated a clinical study to investigate the etiology and epidemiology of central nervous system illness (Meningitis Encephalitis) throughout China.
In August 2020, Massachusetts General Hospital launched a research experiment called GEMMA-Genome Environment Microbiome and Metabolome in Autism to find possible biomarkers predictive of autism development in the blood, feces, urine, and saliva utilizing microbiome/metagenomic/metatranscriptomic analyses.

1 INTRODUCTION OF GLOBAL METAGENOMICS KITS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL METAGENOMICS KITS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL METAGENOMICS KITS MARKET, BY TYPE

5.1 Overview
5.2 Library Preparation Kits
5.3 Metagenomic Sequencing Kits
5.4 Sample Extraction Kits

6 GLOBAL METAGENOMICS KITS MARKET, BY APPLICATION

6.1 Overview
6.2 Drug Discovery
6.3 Clinical Diagnostics
6.4 Environmental Applications
6.5 Others

7 GLOBAL METAGENOMICS KITS MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL METAGENOMICS KITS MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Perkin Elmer Inc.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Promega Connections
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Thermo Fisher Scientific
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Illumina, Inc.
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Merck KGaA
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 QIAGEN N.V.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Novogene Co., Ltd.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Bio-Rad Laboratories Inc.
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 BGI Group
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 DNAstar, Inc.
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments